Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: DeLong Mark Jeffrey, officer

Transaction date: Jan. 20, 2026

Reporting date: Jan. 21, 2026

Average share price: 19.7929

Sold 1334.0 shares for 26403.73